The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
Abstract
Deficiency in vitamin D and its active metabolites is a pathologic feature of chronic kidney diseases. Despite that tubular epithelial cells are the major sites of active vitamin D synthesis, little is known about the role of vitamin D in maintaining the structural and functional integrity of tubular epithelium. This study investigated the effects of paricalcitol (19-nor-1,25-hydroxy-vitamin D(2)), a synthetic vitamin D analogue, on obstructive nephropathy, a model that is characterized by predominant tubulointerstitial lesions. Compared with vehicle controls, paricalcitol significantly attenuated renal interstitial fibrosis in mouse kidney after ureteral obstruction, as demonstrated by a reduced interstitial volume, decreased collagen deposition, and repressed mRNA expression of fibronectin and type I and type III collagens. Paricalcitol largely preserved E-cadherin and reduced alpha-smooth muscle actin expression in vivo. In addition, paricalcitol suppressed renal TGF-beta1 and its type I receptor expression, restored vitamin D receptor abundance, and inhibited cell proliferation and apoptosis after obstructive injury. In vitro, paricalcitol abolished TGF-beta1-mediated E-cadherin suppression and alpha-smooth muscle actin and fibronectin induction in tubular epithelial cells, underscoring its ability to block directly the epithelial to mesenchymal transition (EMT). It is interesting that paricalcitol almost completely suppressed renal induction of Snail, a critical transcription factor that is implicated in EMT programming. Furthermore, paricalcitol inhibited the TGF-beta1-mediated Snail induction in vitro, and ectopic expression of Snail repressed E-cadherin promoter activity and downregulated E-cadherin expression in tubular epithelial cells. These studies suggest that paricalcitol is able to ameliorate renal interstitial fibrosis in obstructive nephropathy, possibly by preserving tubular epithelial integrity through suppression of EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Self-citationRenal fibrosis: New insights into the pathogenesis and therapeutics
Liu, Y. (2006) · Kidney International · doi:10.1038/sj.ki.5000054 · Cited by 1,089
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Self-citationSurvival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19270 · Cited by 831
Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102028 · Cited by 802
Yang, J., & Liu, Y. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62533-3 · Cited by 751
Self-citationTGF-ß Signaling in Renal Disease
Bo[Combining Diaeresis]ttinger, E. P., & Bitzer, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000033611.79556.ae · Cited by 711
Molecular basis of renal fibrosis
Eddy, A. A. (2000) · Pediatric Nephrology · doi:10.1007/s004670000461 · Cited by 637
López-De León, A., & Rojkind, M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.8.2410480 · Cited by 616
Sadeghi, K., Wessner, B., Laggner, U., Ploder, M., Tamandl, D., Friedl, J., Zügel, U., Steinmeyer, A., Pollak, A., Roth, E., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200425995 · Cited by 513
Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., & Kato, S. (1999) · Science · doi:10.1126/science.283.5406.1317 · Cited by 445
Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease
González, E. A., Sachdeva, A., Oliver, D. A., & Martin, K. J. (2004) · American Journal of Nephrology · doi:10.1159/000081023 · Cited by 442
LaClair, R. E., Hellman, R. N., Karp, S. L., Kraus, M., Ofner, S., Li, Q., Graves, K. L., & Moe, S. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.029 · Cited by 407
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
Sprague, S. M., Llach, F., Amdahl, M., Taccetta, C., & Batlle, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00878.x · Cited by 392
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Agarwal, R., Acharya, M., Tian, J., Hippensteel, R. L., Melnick, J. Z., Qiu, P., Williams, L., & Batlle, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00755.x · Cited by 377
Vitamin D and calcium deficits predispose for multiple chronic diseases
Peterlik, M., & Cross, H. S. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01487.x · Cited by 339
Li, Y., Yang, J., Dai, C., Wu, C., & Liu, Y. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17913 · Cited by 337
Self-citationYang, J., & Liu, Y. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13196 · Cited by 326
Self-citationMechanisms of gene regulation by vitamin D3 receptor: a network of coactivator interactions
Rachez, C., & Freedman, L. P. (2000) · Gene · doi:10.1016/s0378-1119(00)00052-4 · Cited by 323
Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
Andress, D. L. (2006) · Kidney International · doi:10.1038/sj.ki.5000045 · Cited by 309
Pálmer, H. G., Larriba, M. J., García, J. M., Ordóñez-Morán, P., Peña, C., Peiró, S., Puig, I., Rodríguez, R., de la Fuente, R., Bernad, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1095 · Cited by 286
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
Schwarz, U., Amann, K., Orth, S. R., Simonaviciene, A., Wessels, S., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00951.x · Cited by 249
Yang, J., Shultz, R. W., Mars, W. M., Wegner, R. E., Li, Y., Dai, C., Nejak, K., & Liu, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16219 · Cited by 228
Self-citationA chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14040 · Cited by 207
VITAMIN D IN HEALTH AND DISEASE: Vitamin D for Health and in Chronic Kidney Disease
Holick, M. F. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18402.x · Cited by 191
Peña, C., García, J. M., Silva, J., García, V., Rodríguez, R., Alonso, I., Millán, I., Salas, C., de Herreros, A. G., Muñoz, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi366 · Cited by 191
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis
Wu, M.-J., Wen, M.-C., Chiu, Y.-T., Chiou, Y.-Y., Shu, K.-H., & Tang, M.-J. (2006) · Kidney International · doi:10.1038/sj.ki.5000161 · Cited by 164
Yang, J., Dai, C., & Liu, Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031827.16102.c1 · Cited by 153
Self-citation25-Hydroxyvitamin D Deficiency in Renal Transplant Recipients
Querings, K., Girndt, M., Geisel, J., Georg, T., Tilgen, W., & Reichrath, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0547 · Cited by 146
Vidal, M., Ramana, C. V., & Dusso, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2777-2787.2002 · Cited by 136
Vitamin D signaling is modulated on multiple levels in health and disease
Ebert, R., Schütze, N., Adamski, J., & Jakob, F. J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.039 · Cited by 118
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
Panichi, V., MIGLIORI, M., Taccola, D., Filippi, C., Nisco, L. D., Giovannini, L., Palla, R., Tetta, C., & Camussi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00775.x · Cited by 114
Li, Y., Spataro, B. C., Yang, J., Dai, C., & Liu, Y. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00562.x · Cited by 107
Self-citationTranscriptional Targets of the Vitamin D3 Receptor–Mediating Cell Cycle Arrest and Differentiation
Freedman, L. P. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.581s · Cited by 91
Mechanism of vitamin D action and its regulation
Dusso, A., & Brown, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9808140 · Cited by 89
Lu, X., FARMER, P. K., Rubin, J. E., & Nanes, M. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20143 · Cited by 80
Malluche, H. H., Mawad, H. W., & Koszewski, N. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00450.x · Cited by 67
Cited by
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Self-citationNew Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870
Self-citationMechanisms of Tubulointerstitial Fibrosis
Zeisberg, M., & Neilson, E. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080793 · Cited by 868
de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., Ritz, E., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61032-x · Cited by 695
Metadata
- Authors
- Tan, X., Li, Y., & Liu, Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-12
- Volume
- 17
- Issue
- 12
- Pages
- 3382-3393
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2133750359
- Cited by
- 280
- References
- 41
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.